
EU GMP Annex 22: AI Pulse Check panelists say most manufacturers aren’t ready, static AI models likely stay central, and local AI deployment grows.
The company announced that its facilities and laboratories have completed FDA pre-qualification inspection.
On July 19, 2016, Quay Pharma announced that its laboratories and manufacturing facilities have completed FDA pre-qualification inspection. The inspection confirmed that the company’s systems are GMP compliant and no deficiencies were identified. Quay recently invested £3 million (approximately $3.93 million) in GMP manufacturing suites. The company also recently received a Commercial License from the Medicines and Healthcare Products Regulatory Agency.
Source: Quay Pharma





